Skip to main content
SpringerLink
Log in

Knowledge Gaps in the Management of Postoperative Crohn’s Disease: A US National Survey

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Postoperative recurrence (POR) of Crohn’s disease (CD) is common. Guidelines on POR management have recently been issued, but clinical practice may vary.

Aims

To examine the current clinical practice of POR management in the USA

Methods

A web-based survey was sent to all members of the American Gastroenterological Association and the American College of Gastroenterology. The survey consisted of multiple-choice questions with clinical scenarios to assess how participants manage POR.

Results

A total of 189 responses were received from practices in 34 states. 44% of participants were from academic settings. The median number of CD patients seen each month was 20–30 patients per participant. The majority of participants considered smoking, prior intestinal surgery, penetrating disease, perianal fistula, early disease onset, and long extent of disease as high-risk factors for POR. To diagnose and grade endoscopic recurrence, 57% of participants used an endoscopic scoring system; 86% defined clinical recurrence using a combination of symptoms and endoscopic findings; and 79% of participants routinely performed colonoscopy after surgery. In high-risk patients, 65% offered medical prophylaxis—most often biologics and/or immunomodulators—immediately after surgery, while 34% offered medical prophylaxis regardless of the patient’s risk of POR. 64% of participants never stopped medical prophylaxis once initiated.

Conclusions

Most gastroenterologists routinely perform colonoscopy to guide POR management. The majority of these providers continue medical prophylaxis indefinitely regardless of subsequent endoscopic findings. Further research is needed to determine the risks and benefits of continuing versus deescalating therapy in patients with potentially surgically induced remission.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Regueiro M, Velayos F, et al. American gastroenterological association institute technical review on the management of Crohn’s disease after surgical resection. Gastroenterology. 2017;152:277–295. https://doi.org/10.1053/j.gastro.2016.10.039.

    Article  PubMed  Google Scholar 

  2. Buisson A, Chevaux J-B, Allen PB, Bommelaer G, Peyrin-Biroulet L. Review article: the natural history of postoperative Crohn’s disease recurrence. Aliment Pharmacol Ther. 2012;35:625–633. https://doi.org/10.1111/j.1365-2036.2012.05002.x.

    Article  CAS  PubMed  Google Scholar 

  3. Nguyen GC, Loftus EV, Hirano I, et al. American gastroenterological association institute guideline on the management of Crohn’s disease after surgical resection. Gastroenterology. 2017;152:271–275. https://doi.org/10.1053/j.gastro.2016.10.038.

    Article  PubMed  Google Scholar 

  4. De Cruz P, Kamm MA, Hamilton AL, et al. Crohn’s disease management after intestinal resection: a randomised trial. Lancet Lond Engl. 2015;385:1406–1417. https://doi.org/10.1016/S0140-6736(14)61908-5.

    Article  Google Scholar 

  5. D’Haens G, Vermeire S, Van Assche G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn’s disease: a controlled randomized trial. Gastroenterology. 2008;135:1123–1129.

    Article  PubMed  Google Scholar 

  6. Nguyen V, Kanth R, Gazo J, Sorrentino D. Management of post-operative Crohn’s disease in 2017: where do we go from here? Expert Rev Gastroenterol Hepatol. 2017;2016:1–13. https://doi.org/10.1080/17474124.2016.1241708.

    Google Scholar 

  7. Hashash JG, Regueiro M. A practical approach to preventing postoperative recurrence in Crohn’s disease. Curr Gastroenterol Rep. 2016;18:25. https://doi.org/10.1007/s11894-016-0499-8.

    Article  PubMed  Google Scholar 

  8. Sorrentino D, Terrosu G, Avellini C, Beltrami CA, Bresadola V, Toso F. Prevention of postoperative recurrence of Crohn’s disease by infliximab. Eur J Gastroenterol Hepatol. 2006;18:457–459.

    Article  PubMed  Google Scholar 

  9. Sorrentino D, Terrosu G, Avellini C, Maiero S. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. Arch Intern Med. 2007;167:1804–1807.

    Article  PubMed  Google Scholar 

  10. Regueiro M, Schraut W, Baidoo L, et al. Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology. 2009;136:441–450.

    Article  CAS  PubMed  Google Scholar 

  11. Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC. Interventions for prevention of post-operative recurrence of Crohn’s disease. Cochrane Database Syst Rev. 2009;4:CD006873. https://doi.org/10.1002/14651858.CD006873.

    Google Scholar 

  12. Nguyen DL, Solaimani P, Nguyen ET, Jamal MM, Bechtold ML. Antitumor necrosis factor α is more effective than conventional medical therapy for the prevention of postoperative recurrence of Crohn’s disease: a meta-analysis. Eur J Gastroenterol Hepatol. 2014;26:1152–1159. https://doi.org/10.1097/MEG.0000000000000178.

    Article  CAS  PubMed  Google Scholar 

  13. Burke JP, Doherty GA, O’Connell PR. A survey of current practices used to maintain surgically induced remission following intestinal resection for Crohn’s disease. Int J Colorectal Dis. 2013;28:1073–1079. https://doi.org/10.1007/s00384-013-1668-y.

    Article  PubMed  Google Scholar 

  14. Ong M-S, Grand RJ, Mandl KD. Trends in pharmacologic interventions for preventing recurrence of Crohn’s disease after ileocolonic surgery. Inflamm Bowel Dis. 2016;22:2432–2441. https://doi.org/10.1097/MIB.0000000000000898.

    Article  PubMed  Google Scholar 

  15. Domènech E, Garcia V, Iborra M, et al. Incidence and management of recurrence in patients with Crohn’s disease who have undergone intestinal resection: the practicrohn study. Inflamm Bowel Dis. 2017. https://doi.org/10.1097/MIB.0000000000001180.

    PubMed  Google Scholar 

  16. Regueiro M, Feagan BG, Zou B, et al. Infliximab reduces endoscopic, but not clinical, recurrence of Crohn’s disease after ileocolonic resection. Gastroenterology. 2016;150:1568–1578. https://doi.org/10.1053/j.gastro.2016.02.072.

    Article  CAS  PubMed  Google Scholar 

  17. Mowat C, Arnott I, Cahill A, et al. Mercaptopurine versus placebo to prevent recurrence of Crohn’s disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial. Lancet Gastroenterol Hepatol. 2016;1:273–282. https://doi.org/10.1016/S2468-1253(16)30078-4.

    Article  PubMed  Google Scholar 

  18. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn’s disease. Gastroenterology. 1990;99:956–963.

    Article  CAS  PubMed  Google Scholar 

  19. Walters TD, Steinhart AH, Bernstein CN, et al. Validating Crohn’s disease activity indices for use in assessing postoperative recurrence. Inflamm Bowel Dis. 2011;17:1547–1556. https://doi.org/10.1002/ibd.21524.

    Article  CAS  PubMed  Google Scholar 

  20. Viscido A, Corrao G, Taddei G, Caprilli R. “Crohn’s disease activity index” is inaccurate to detect the post-operative recurrence in Crohn’s disease. A GISC study. Gruppo Italiano per lo Studio del Colon e del Retto. Ital J Gastroenterol Hepatol. 1999;31:274–279.

    CAS  PubMed  Google Scholar 

  21. Regueiro M, Kip KE, Schraut W, et al. Crohn’s disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection. Inflamm Bowel Dis. 2011;17:118–126. https://doi.org/10.1002/ibd.21355.

    Article  PubMed  Google Scholar 

  22. Robb PM, Sorrentino D. Long-term prevention of postoperative Crohn’s disease recurrence with azathioprine: the wolf in the sheep clothing. Int J Colorectal Dis. 2015;30:283–284. https://doi.org/10.1007/s00384-014-1984-x.

    Article  PubMed  Google Scholar 

  23. Peyrin-Biroulet L, Oussalah A, Roblin X, Sparrow MP. The use of azathioprine in Crohn’s disease during pregnancy and in the postoperative setting: a worldwide survey of experts. Aliment Pharmacol Ther. 2011;33:707–713.

    Article  CAS  PubMed  Google Scholar 

  24. Beaugerie L, Brousse N, Bouvier AM, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009;374:1617–1625.

    Article  CAS  PubMed  Google Scholar 

  25. Kotlyar DS, Lewis JD, Beaugerie L, et al. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. Clin Gastroenterol Hepatol. 2015;13:847–858.

    Article  CAS  PubMed  Google Scholar 

  26. Sorrentino D, Paviotti A, Terrosu G, Avellini C, Geraci M, Zarifi D. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn’s disease. Clin Gastroenterol Hepatol. 2010;8:591–599.

    Article  CAS  PubMed  Google Scholar 

  27. Sorrentino D, Marino M, Dassopoulos T, Zarifi D, Del Bianco T. Low dose infliximab for prevention of postoperative recurrence of Crohn’s Disease: long term follow-up and impact of infliximab trough levels and antibodies to infliximab. PloS One. 2015;10:e0144900. https://doi.org/10.1371/journal.pone.0144900.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Doherty GA, Miksad RA, Cheifetz AS, Moss AC. Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn’s disease. Inflamm Bowel Dis. 2012;18:1608–1616. https://doi.org/10.1002/ibd.21904.

    Article  PubMed  Google Scholar 

  29. Tremaine WJ. Nine medico-legal pitfalls in inflammatory bowel disease in the United States. Curr Drug Targets. 2014;15:1039–1041.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

Grant support: this research was supported by an internal research grant from Virginia Tech Carilion.

Author information

Authors and Affiliations

  1. IBD Center, Division of Gastroenterology, Virginia Tech Carilion School of Medicine, 3 Riverside Circle, 3rd Floor Gastroenterology, Roanoke, VA, 24016, USA

    Vu Q. Nguyen, Jessica L. Mays, Marissa Lang, Yingxing Wu & Dario Sorrentino

  2. IBD Center, Division of Gastroenterology, Baylor Medical Center, Dallas, TX, USA

    Themistocles Dassopoulos

  3. Division of Gastroenterology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

    Miguel Regueiro

  4. Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA, USA

    Alan Moss

  5. Division of Gastroenterology, Yale University School of Medicine, New Haven, CT, USA

    Deborah D. Proctor

  6. Department of Clinical and Experimental Medical Sciences, University of Udine School of Medicine, Udine, Italy

    Dario Sorrentino

Authors
  1. Vu Q. Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jessica L. Mays
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marissa Lang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yingxing Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Themistocles Dassopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Miguel Regueiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Alan Moss
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Deborah D. Proctor
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Dario Sorrentino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dario Sorrentino.

Ethics declarations

Conflict of interest

The authors declared no conflicts of interest related to this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nguyen, V.Q., Mays, J.L., Lang, M. et al. Knowledge Gaps in the Management of Postoperative Crohn’s Disease: A US National Survey. Dig Dis Sci 63, 53–60 (2018). https://doi.org/10.1007/s10620-017-4844-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-017-4844-z

Keywords

Search

Navigation